Wuxi AppTec CoWUXIF 84 PEG Ratio is 0.42 as of Jun. 29, 2026, which is 19% below its 10-year median of 0.52. GuruFocus rates WUXIF with a GF Score™ of 84/100 and a GF Value™ of $11.26 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 36 Medical Diagnostics & Research companies, Wuxi AppTec Co ranks better than 86.11% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Wuxi AppTec Co's PEG Ratio or its related term are showing as below:
WUXIF'
s PEG Ratio Range Over the Past 10 Years
Min: 0.26 Med: 0.52 Max: 6.71
Current: 0.45
During the past 12 years, Wuxi AppTec Co's highest PEG Ratio was 6.71. The lowest was 0.26. And the median was 0.52.
WUXIF's PEG Ratio is ranked better than 86.11% of 36
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.27
vs WUXIF: 0.45
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Wuxi AppTec Co (OTCPK:WUXIF) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Wuxi AppTec Co PEG Ratio Related Terms
Wuxi AppTec Co PEG Ratio Historical Data
* Premium members only.
The historical data trend for Wuxi AppTec Co's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Wuxi AppTec Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wuxi AppTec Co PEG Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Wuxi AppTec Co's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Wuxi AppTec Co's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Wuxi AppTec Co (WUXIF) has a PEG Ratio of 0.42 as of Jun. 29, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Wuxi AppTec Co and its competitors. This is 19% below median its historical median of 0.52. Over the past decade, Wuxi AppTec Co's PEG Ratio has ranged from 0.26 to 6.71. According to the industry distribution chart, Wuxi AppTec Co ranks #5 out of 36 companies in the Medical Diagnostics & Research industry, placing it in the top 13.9%.
Is Wuxi AppTec Co's PEG Ratio too high?
Wuxi AppTec Co's current PEG Ratio of 0.42 is 19% below median its 10-year median of 0.52. Over the past 10 years, this metric has ranged from a low of 0.26 to a high of 6.71. The Medical Diagnostics & Research industry median PEG Ratio is 2.27. Wuxi AppTec Co's value of 0.42 is 81.5% below this industry median. Based on the distribution chart, Wuxi AppTec Co ranks #5 out of 36 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Wuxi AppTec Co has a GF Score™ of 84/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Wuxi AppTec Co's PEG Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Wuxi AppTec Co ranks #5 out of 36 companies for PEG Ratio. This places Wuxi AppTec Co in the top 14% of its industry — outperforming the majority of peers. The industry median PEG Ratio is 2.27. Wuxi AppTec Co's value of 0.42 is 81.5% below this benchmark. Historically, Wuxi AppTec Co's own PEG Ratio has ranged from 0.26 to 6.71 over the past decade. While the company's 10-year median is 0.52 vs. the industry median of 2.27, Wuxi AppTec Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Diagnostics & Research company?
The median PEG Ratio among Medical Diagnostics & Research companies is 2.27, based on 36 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wuxi AppTec Co's current PEG Ratio of 0.42 is 81.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Wuxi AppTec Co and its competitors. For the Medical Diagnostics & Research industry, the median PEG Ratio is 2.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wuxi AppTec Co's current PEG Ratio is 0.42, which is 19% below median its own 10-year median of 0.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wuxi AppTec Co stock overvalued right now?
Based on GuruFocus' analysis, Wuxi AppTec Co (WUXIF) is currently considered Significantly Overvalued. The stock's GF Value™ is $11.26, compared to a current price of $15.63 — trading 38.8% above its estimated fair value. The current PEG Ratio is 0.42, which is 19% below median its 10-year median of 0.52 and 81.5% below the Medical Diagnostics & Research industry median of 2.27. Wuxi AppTec Co's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Wuxi AppTec Co (WUXIF), the current PEG Ratio is 0.42 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Wuxi AppTec Co (WUXIF) Overvalued in 2026?
Based on GuruFocus' analysis, Wuxi AppTec Co stock appears to be overvalued.
The current stock price of $15.63 is trading 38.8% above its estimated GF Value™ of $11.26.
GuruFocus considers Wuxi AppTec Co to be Significantly Overvalued.
Key valuation signals for WUXIF:
PEG Ratio: 0.42 (19% below median its 10-year median of 0.52)
GF Value™: $11.26 vs. price of $15.63 (38.8% above fair value)
Industry Position: 81.5% below the Medical Diagnostics & Research median (#5 of 36)
No single metric tells the full story. See the WUXIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by PRC, Europe, and other regions.
84GF Score
Get the complete analysis for WUXIF
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WUXIF has been successfully added to your 
